Stock RLAY RELAY THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Relay Therapeutics, Inc.

Equities

RLAY

US75943R1023

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
7.345 USD +4.33% Intraday chart for Relay Therapeutics, Inc. +18.66% -33.29%
Jun. 05 Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment DJ
Jun. 05 Relay Therapeutics to Collaborate With Pfizer to Evaluate Metastatic Breast Cancer Treatment MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment
DJ
Relay Therapeutics to Collaborate With Pfizer to Evaluate Metastatic Breast Cancer Treatment
MT
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
GL
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
AQ
Relay Therapeutics to Participate in Upcoming Investor Conferences
GL
Transcript : Relay Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 01:40 PM
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
GL
Barclays Upgrades Relay Therapeutics to Overweight From Equalweight With $15 Price Target
MT
Oppenheimer Adjusts Relay Therapeutics Price Target to $25 From $33, Maintains Outperform Rating
MT
Earnings Flash (RLAY) RELAY THERAPEUTICS Reports Q1 Revenue $10M
MT
Relay Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
GL
Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024
GL
Relay Therapeutics to Participate in Upcoming Investor Conferences
GL
Transcript : Relay Therapeutics, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 07:30 AM
Relay Therapeutics to Participate in Three Upcoming Investor Conferences
GL
Relay Therapeutics Q4 Loss Widens, Reports No Revenue
MT
Relay Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Relay Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RLAY Stock
  4. News Relay Therapeutics, Inc.